Conferences and Events
Each year Immunet members gather for a conference which also serves as the regional meeting for the New Zealand members of the Australasian Society for Immunology. The meeting is held over two days and features invited prestigious overseas speakers. Local immunologists also have the opportunity to present their work.
Annual Meeting New Zealand Branch of the Australasian Society for Immunology
28-29 June 2012, Dunedin Public Art Gallery
Focus Topics
Human Health, Allergy Autoimmunity, Cancer Immunotherapy, Infectious Diseases & Veterinary Immunology
Download
Download the poster in PDF format.
Download the Abstract Submission Form (in MS Word .doc format)
Download the Registration Form (in MS Word .doc format)
Confirmed Speakers
Troy Randall: Troy is the J. Claude Bennett Professor of Medicine and the University of Alabama at Birmingham, Department of Medicine, Division of Clinical Immunology and Rheumatology. His lab studies the development of bronchus and nasal associated lymphoid tissues (BALT/NALT) to determine how these tissues function to regulate immune responses in allergy, asthma, respiratory infection and vaccination. Troy's current projects include the mechanisms by which the omentum suppresses immune response to peritoneal tumours and maintains tolerance to commensal and food antigens; how local lymphoid tissues such as inducible BALT develop and function; and how CD40 signaling controls CD8 T cell responses.
Anne Kelso: After obtaining her PhD at the University of Melbourne, Anne Kelso pursued her interest in T cell immunology at the Swiss Institute for Experimental Cancer Research, the Walter and Eliza Hall Institute of Medical Research and the Queensland Institute of Medical Research. From 2000 until 2006 at QIMR, she was also Director of the Cooperative Research Centre for Vaccine Technology. In 2007, Anne returned to Melbourne as Director of the WHO Collaborating Centre for Reference and Research on Influenza. She has previously served as president of the Australasian Society for Immunology and as secretary-general of the International Union of Immunological Societies.
Richard Vile: As a consultant in molecular medicine for the Mayo Clinic in Minnesota, Professor Richard Vile’s research interests are primarily focused on the development of gene-, viro- and immuno-therapies for cancer. Using murine models – principally of melanoma, colorectal, lung, prostate and pancreatic cancer – Richard’s team test strategies by which oncolytic viruses can be delivered systemically to metastatic disease. In addition, Richard has a long term interest in defining how the immune system can be re-educated to recognise and react against tumor associated antigens. Funded by three NIH RO1 grants as well as a grant from Biotech, Richard’s pre-clinical studies are focused on translational relevance as well as being involved in three different clinical trials in collaboration with clinical partners in London and Leeds in the UK, Oncolytics Biotech in Canada, and Mayo Clinic Rochester.
